Annual SGA
$95.00 M
+$59.82 M+170.02%
December 31, 2023
Summary
- As of February 26, 2025, VRDN annual SGA is $95.00 million, with the most recent change of +$59.82 million (+170.02%) on December 31, 2023.
- During the last 3 years, VRDN annual SGA has risen by +$81.73 million (+616.16%).
- VRDN annual SGA is now at all-time high.
Performance
VRDN SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$14.41 M
-$1.66 M-10.32%
September 30, 2024
Summary
- As of February 26, 2025, VRDN quarterly SGA is $14.41 million, with the most recent change of -$1.66 million (-10.32%) on September 30, 2024.
- Over the past year, VRDN quarterly SGA has dropped by -$6.50 million (-31.10%).
- VRDN quarterly SGA is now -56.33% below its all-time high of $32.99 million, reached on December 31, 2023.
Performance
VRDN Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$3.26 B
-$257.08 M-8.57%
September 30, 2024
Summary
- As of February 26, 2025, VRDN TTM SGA is -$3.26 billion, with the most recent change of -$257.08 million (-8.57%) on September 30, 2024.
- Over the past year, VRDN TTM SGA has dropped by -$3.33 billion (-4630.94%).
- VRDN TTM SGA is now -13530.56% below its all-time high of -$23.89 million.
Performance
VRDN TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
VRDN Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +170.0% | -31.1% | -4630.9% |
| 3 y3 years | +616.2% | -31.1% | -4630.9% |
| 5 y5 years | +759.8% | -31.1% | -4630.9% |
VRDN Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +268.1% | -56.3% | +108.8% | -150.4% | at low |
| 5 y | 5-year | at high | +715.7% | -56.3% | +526.7% | -432.9% | at low |
| alltime | all time | at high | +5297.7% | -56.3% | +3738.0% | <-9999.0% | at low |
Viridian Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $14.41 M(-10.3%) | $78.49 M(-7.7%) |
| Jun 2024 | - | $16.07 M(+6.9%) | $85.00 M(-3.6%) |
| Mar 2024 | - | $15.03 M(-54.5%) | $88.19 M(-7.2%) |
| Dec 2023 | $95.00 M(+170.0%) | $32.99 M(+57.8%) | $95.00 M(+32.2%) |
| Sep 2023 | - | $20.91 M(+8.5%) | $71.86 M(+20.1%) |
| Jun 2023 | - | $19.26 M(-11.8%) | $59.81 M(+22.9%) |
| Mar 2023 | - | $21.83 M(+121.5%) | $48.65 M(+38.3%) |
| Dec 2022 | $35.18 M(+36.3%) | $9.85 M(+11.2%) | $35.18 M(+9.2%) |
| Sep 2022 | - | $8.86 M(+9.3%) | $32.23 M(+8.9%) |
| Jun 2022 | - | $8.11 M(-3.0%) | $29.59 M(+5.7%) |
| Mar 2022 | - | $8.36 M(+21.1%) | $28.00 M(+8.5%) |
| Dec 2021 | $25.80 M(+94.5%) | $6.90 M(+10.9%) | $25.80 M(+5.6%) |
| Sep 2021 | - | $6.22 M(-4.6%) | $24.44 M(+19.1%) |
| Jun 2021 | - | $6.52 M(+5.9%) | $20.52 M(+22.9%) |
| Mar 2021 | - | $6.16 M(+11.3%) | $16.70 M(+25.9%) |
| Dec 2020 | $13.27 M(+13.9%) | $5.54 M(+140.8%) | $13.27 M(+29.3%) |
| Sep 2020 | - | $2.30 M(-15.0%) | $10.26 M(-5.5%) |
| Jun 2020 | - | $2.71 M(-0.6%) | $10.86 M(-1.4%) |
| Mar 2020 | - | $2.72 M(+7.5%) | $11.01 M(-5.4%) |
| Dec 2019 | $11.65 M(+5.4%) | $2.53 M(-12.6%) | $11.65 M(-1.4%) |
| Sep 2019 | - | $2.90 M(+1.4%) | $11.81 M(+1.7%) |
| Jun 2019 | - | $2.86 M(-14.9%) | $11.61 M(+1.7%) |
| Mar 2019 | - | $3.36 M(+24.6%) | $11.42 M(+3.3%) |
| Dec 2018 | $11.05 M | $2.69 M(-0.0%) | $11.05 M(+1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $2.70 M(+1.0%) | $10.90 M(+1.8%) |
| Jun 2018 | - | $2.67 M(-10.8%) | $10.71 M(+0.8%) |
| Mar 2018 | - | $2.99 M(+17.3%) | $10.62 M(-2.7%) |
| Dec 2017 | $10.91 M(+14.0%) | $2.55 M(+1.8%) | $10.91 M(-1.2%) |
| Sep 2017 | - | $2.50 M(-3.1%) | $11.05 M(+6.0%) |
| Jun 2017 | - | $2.58 M(-21.3%) | $10.42 M(+1.8%) |
| Mar 2017 | - | $3.28 M(+22.3%) | $10.24 M(+6.9%) |
| Dec 2016 | $9.57 M(-6.6%) | $2.68 M(+42.7%) | $9.57 M(-0.2%) |
| Sep 2016 | - | $1.88 M(-21.5%) | $9.60 M(-8.7%) |
| Jun 2016 | - | $2.40 M(-8.4%) | $10.52 M(+0.4%) |
| Mar 2016 | - | $2.62 M(-3.2%) | $10.47 M(+2.1%) |
| Dec 2015 | $10.25 M(+35.3%) | $2.70 M(-3.4%) | $10.25 M(+5.7%) |
| Sep 2015 | - | $2.80 M(+19.0%) | $9.70 M(+9.9%) |
| Jun 2015 | - | $2.35 M(-1.9%) | $8.83 M(-6.9%) |
| Mar 2015 | - | $2.40 M(+11.5%) | $9.48 M(+25.2%) |
| Dec 2014 | $7.57 M(+330.3%) | $2.15 M(+11.5%) | $7.57 M(+30.6%) |
| Sep 2014 | - | $1.93 M(-35.8%) | $5.80 M(+31.6%) |
| Jun 2014 | - | $3.00 M(+510.4%) | $4.41 M(+127.1%) |
| Mar 2014 | - | $492.00 K(+31.1%) | $1.94 M(-0.6%) |
| Dec 2013 | $1.76 M(-58.4%) | $375.40 K(-29.9%) | $1.95 M(+23.8%) |
| Sep 2013 | - | $535.40 K(-0.4%) | $1.58 M(+51.4%) |
| Jun 2013 | - | $537.40 K(+6.6%) | $1.04 M(+106.6%) |
| Mar 2013 | - | $503.90 K | $503.90 K |
| Dec 2012 | $4.23 M | - | - |
FAQ
- What is Viridian Therapeutics annual SGA?
- What is the all time high annual SGA for Viridian Therapeutics?
- What is Viridian Therapeutics annual SGA year-on-year change?
- What is Viridian Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Viridian Therapeutics?
- What is Viridian Therapeutics quarterly SGA year-on-year change?
- What is Viridian Therapeutics TTM SGA?
- What is the all time high TTM SGA for Viridian Therapeutics?
- What is Viridian Therapeutics TTM SGA year-on-year change?
What is Viridian Therapeutics annual SGA?
The current annual SGA of VRDN is $95.00 M
What is the all time high annual SGA for Viridian Therapeutics?
Viridian Therapeutics all-time high annual SGA is $95.00 M
What is Viridian Therapeutics annual SGA year-on-year change?
Over the past year, VRDN annual SGA has changed by +$59.82 M (+170.02%)
What is Viridian Therapeutics quarterly SGA?
The current quarterly SGA of VRDN is $14.41 M
What is the all time high quarterly SGA for Viridian Therapeutics?
Viridian Therapeutics all-time high quarterly SGA is $32.99 M
What is Viridian Therapeutics quarterly SGA year-on-year change?
Over the past year, VRDN quarterly SGA has changed by -$6.50 M (-31.10%)
What is Viridian Therapeutics TTM SGA?
The current TTM SGA of VRDN is -$3.26 B
What is the all time high TTM SGA for Viridian Therapeutics?
Viridian Therapeutics all-time high TTM SGA is -$23.89 M
What is Viridian Therapeutics TTM SGA year-on-year change?
Over the past year, VRDN TTM SGA has changed by -$3.33 B (-4630.94%)